Test lung cancer drug response using patient tumor mini-organs
Part of Cancer, Lungs & breathing clinical trials.
This trial grows “organoids” (mini tumor models) from your lung cancer tissue to see which drug responses are most likely. It may help match future treatments to how your tumor behaves in the lab.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of lung cancer based on biopsy or surgery tissue
- You are 18 years or older
- You can understand the study and sign a consent form (and language support is available if needed)
- Your medical team can obtain a tumor sample from either the main tumor or a spread (metastasis) area
- There must be enough lung tissue left after testing so routine pathology can still be done
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a lab-grown model of your tumor (called an organoid) to test whether different drugs might work against it. The goal is to find the best treatment for your specific glioblastoma.
This study looks at lung cancer samples you provide to see how tumor cells respond to treatment. It may help researchers find better ways to choose treatments for lung cancer by testing response in a lab model.
This trial tests whether using a lab-grown 'mini-tumor' (organoid) made from your cancer cells can help pick a more effective treatment for liver cancer that can't be removed with surgery. The goal is to find a drug that works specifically for your cancer.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This study collects samples from your cancer (like during surgery or a biopsy) to grow tiny lab “organoids” for testing. It may help researchers learn which treatments could work better for different cancers.
This study uses a sample of your tumor to grow a mini-tumor in the lab (called an organoid) to see which chemotherapy might work best for you. This could help reduce the chance of cancer coming back after treatment.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.